Group | Mild (%) | Moderate (%) | Total | P |
---|---|---|---|---|
Number of patients | 305 (77.41) | 89 (22.59) | 394 | – |
Nonvaccinated | 49 (16.07) | 15 (16.85) | 64 (16.24) | 0.8592 |
Vaccinated | 256 (83.93) | 74 (84.27) | 330 (83.76) | 0.8592 |
One dose | 29 (9.51) | 1 (1.12) | 30 (7.61) | 0.0087 |
Two doses | 116 (38.03) | 40 (44.94) | 156 (39.59) | 0.2408 |
Three doses | 108 (35.41) | 31 (34.83) | 139 (35.28) | 0.92 |
Four doses | 3 (0.98) | 2 (2.25) | 5 (1.27) | 0.3488 |
Inactivated Viral vaccine | 199 (65.25) | 67 (75.28) | 266 (67.51) | 0.0753 |
mRNA vaccine | 51 (16.72) | 7 (7.87) | 58 (14.72) | 0.0038 |
viral vector vaccine | 5 (1.64) | 0 (0) | 5 (1.27) | 0.2241 |
Recombinant subunit vaccine | 1 (0.33) | 0 (0) | 1 (0.25) | 0.5886 |